ERD

Sort by

European Partnerships

Show in overview

EU-Programme-Call

Show in overview

7 items found

Toggle all information

EU-ToxRisk | An Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century

01-01-2016

31-12-2021

Show more information

Organisation TISSUSE GMBH

RISK-HUNT3R | RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs

01-06-2021

31-05-2026

Show more information

Organisation TISSUSE GMBH

TOP-GUT | Training for Organoids modelling Physiology and Pathology in the human gastrointestinal tract

01-11-2023

31-10-2027

Show more information

Organisation TISSUSE GMBH

geneTIGA | Gene-edited T cells combating IgA Nephropathy. A blueprint approach for safe & efficient genome editing of T cells to sustainably combat several immune diseases and cancers related to B-cell pathology

01-07-2022

30-06-2026

Show more information

Organisation TISSUSE GMBH

RESHAPE | Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials

01-01-2019

31-12-2024

Show more information

Organisation TISSUSE GMBH

RESTORE | RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients

01-03-2019

31-07-2020

Show more information

Organisation TISSUSE GMBH

BIRDIE | Bioprinting on-chip microphysiological models of humanized kidney tubulointerstitium

01-03-2021

28-02-2025

Show more information

Organisation TISSUSE GMBH

Projects overview

Selected filters:

EU-ToxRisk | An Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century

RISK-HUNT3R | RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs

TOP-GUT | Training for Organoids modelling Physiology and Pathology in the human gastrointestinal tract

geneTIGA | Gene-edited T cells combating IgA Nephropathy. A blueprint approach for safe & efficient genome editing of T cells to sustainably combat several immune diseases and cancers related to B-cell pathology

RESHAPE | Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials

RESTORE | RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients

BIRDIE | Bioprinting on-chip microphysiological models of humanized kidney tubulointerstitium